Among other things, the order requires the Food and Drug Administration to increase its reporting of possible shortages of certain prescription drugs, while also speeding up regulatory reviews of new drug manufacturing sites, drug suppliers and manufacturing changes.
Drug manufacturers are being encouraged to voluntarily disclose possible prescription drug shortages in instances not currently required by law.
The total number of prescription drug shortages almost tripled from 2005 to 2010, the White House noted.
"As we have said throughout this initiative and in general, the president looks to ways he can use his executive authority to, broadly speaking, help Americans who can be helped through actions that this administration can take."